BioTelemetry Stock News

New York, March 03, 2020 -- Reportlinker.com announces the release of the report "Global Wearable Medical Devices Market 2020-2024" -.

New York, March 03, 2020 -- Reportlinker.com announces the release of the report "Global Cardiovascular Disease Monitoring and Diagnostic Devices Industry" -.

Cardiovascular Disease Monitoring and Diagnostic Devices market worldwide is projected to grow by US$1.2 Billion, driven by a compounded growth of 7%. ECG Systems, one of the segments analyzed and siz

According to the current analysis of Reports and Data, the cardiac rehabilitation market was valued at USD 1.37 billion in 2018 and is expected to reach USD 2.29 billion by the year 2026, at a CAGR

BioTelemetry (NASDAQ:BEAT) was downgraded by BidaskClub from a “buy” rating to a “hold” rating in a research report issued on Saturday, BidAskClub reports. A number of other equities analysts

BioTelemetry (NASDAQ:BEAT) had its target price reduced by Sidoti from $81.00 to $75.00 in a research report report published on Thursday morning, BenzingaRatingsTable reports. Sidoti currently has a

Banque Cantonale Vaudoise acquired a new position in shares of BioTelemetry Inc (NASDAQ:BEAT) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities an

Altshuler Shaham Ltd raised its stake in BioTelemetry Inc (NASDAQ:BEAT) by 8.2% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 5,300 shares of the medical researc

BioTelemetry Inc (NASDAQ:BEAT) saw a large increase in short interest in the month of February. As of February 14th, there was short interest totalling 3,040,000 shares, an increase of 7.4% from the J

BioTelemetry Inc (NASDAQ:BEAT) – Equities researchers at Dougherty & Co issued their FY2021 earnings per share estimates for shares of BioTelemetry in a note issued to investors on Thursday, Februar

Raid bosses are usually tough, but there are specific weaknesses to every single one of them! Nidorino in Pokemon Go is no exemption to this list. Find out how to beat this raid boss easily!

Los Angeles Capital Management & Equity Research Inc. cut its holdings in shares of BioTelemetry Inc (NASDAQ:BEAT) by 25.0% during the fourth quarter, Holdings Channel reports. The firm owned 5,663 sh

Zacks Investment Research downgraded shares of BioTelemetry (NASDAQ:BEAT) from a hold rating to a sell rating in a research note issued to investors on Wednesday morning, Zacks.com reports. According

TheStreet cut shares of BioTelemetry (NASDAQ:BEAT) from a b- rating to a c rating in a research report sent to investors on Wednesday morning, TheStreetRatingsTable reports. BEAT has been the subject

BioTelemetry Inc (NASDAQ:BEAT) – Research analysts at SunTrust Banks decreased their Q1 2020 earnings per share estimates for BioTelemetry in a report issued on Wednesday, February 26th. SunTrust Ba